Conjugates of Cryptophycin and RGD or
antitumor agents
cancer
drug delivery
integrins
peptidomimetics
Journal
ChemistryOpen
ISSN: 2191-1363
Titre abrégé: ChemistryOpen
Pays: Germany
ID NLM: 101594811
Informations de publication
Date de publication:
Jun 2019
Jun 2019
Historique:
received:
27
03
2019
revised:
16
04
2019
entrez:
6
7
2019
pubmed:
6
7
2019
medline:
6
7
2019
Statut:
epublish
Résumé
RGD-cryptophycin and
Identifiants
pubmed: 31275795
doi: 10.1002/open.201900110
pii: OPEN201900110
pmc: PMC6587324
doi:
Types de publication
Journal Article
Langues
eng
Pagination
737-742Déclaration de conflit d'intérêts
A.M. is an employee of Exiris, P.G. is a shareholder of Exiris. C.S. is a shareholder of Exiris.
Références
Beilstein J Org Chem. 2018 Feb 14;14:407-415
pubmed: 29520305
Chemistry. 2009 Nov 16;15(45):12184-8
pubmed: 19830748
Angew Chem Int Ed Engl. 2014 Apr 7;53(15):3796-827
pubmed: 24677743
Adv Ther. 2017 May;34(5):1015-1035
pubmed: 28361465
Lung Cancer. 2003 Feb;39(2):197-9
pubmed: 12581573
Pharm Res. 2015 Nov;32(11):3526-40
pubmed: 25759187
Future Med Chem. 2017 Apr;9(6):579-604
pubmed: 28394627
Curr Med Chem. 2010;17(13):1255-99
pubmed: 20166941
Mol Pharm. 2018 Sep 4;15(9):3603-3616
pubmed: 29553749
Chemistry. 2017 Oct 17;23(58):14410-14415
pubmed: 28816404
Int J Gynecol Cancer. 2006 Jan-Feb;16(1):71-6
pubmed: 16445613
Biochem Biophys Res Commun. 2016 Sep 23;478(3):1280-5
pubmed: 27553273
J Clin Invest. 1992 Jun;89(6):2018-22
pubmed: 1376331
Int J Cancer. 1998 Sep 11;77(6):869-73
pubmed: 9714056
Chemistry. 2015 Apr 27;21(18):6921-9
pubmed: 25784522
J Med Chem. 2013 Mar 14;56(5):1853-64
pubmed: 23387527
Mol Pharm. 2012 Nov 5;9(11):2961-73
pubmed: 22967287
Br J Cancer. 2004 Feb 9;90(3):561-5
pubmed: 14760364
J Pept Sci. 2017 Jul;23(7-8):514-531
pubmed: 28661555
Chemistry. 2013 Mar 11;19(11):3563-7
pubmed: 23424096
Bioorg Med Chem Lett. 2015 Feb 15;25(4):864-8
pubmed: 25613677
ChemistryOpen. 2019 Jun 07;8(6):737-742
pubmed: 31275795
Pharmaceutics. 2019 Apr 01;11(4):
pubmed: 30939768
Nat Rev Drug Discov. 2015 Mar;14(3):203-19
pubmed: 25698644
Nat Rev Drug Discov. 2017 May;16(5):315-337
pubmed: 28303026
Beilstein J Org Chem. 2018 Jun 1;14:1281-1286
pubmed: 29977395
J Cell Sci. 2011 Feb 15;124(Pt 4):515-22
pubmed: 21282473
Clin Exp Metastasis. 2002;19(5):427-36
pubmed: 12198771
J Biol Chem. 2008 Jul 11;283(28):19757-68
pubmed: 18480047
Angew Chem Int Ed Engl. 2012 Jul 27;51(31):7702-5
pubmed: 22718573
Future Med Chem. 2018 Sep 1;10(18):2201-2226
pubmed: 30043641
J Med Chem. 2012 Dec 13;55(23):10460-74
pubmed: 23140358
Nat Rev Cancer. 2018 Sep;18(9):533-548
pubmed: 30002479
Chemistry. 2017 Jun 12;23(33):7910-7914
pubmed: 28449309
Nat Rev Cancer. 2008 Aug;8(8):604-17
pubmed: 18497750
Angew Chem Int Ed Engl. 2013 Jan 28;52(5):1384-402
pubmed: 23296451
J Biol Chem. 1987 Dec 25;262(36):17703-11
pubmed: 2447074
J Med Chem. 2018 Sep 13;61(17):7474-7485
pubmed: 29883545
Biol Open. 2012 Apr 15;1(4):329-40
pubmed: 23213423
Sci Rep. 2017 Jan 11;7:39805
pubmed: 28074920
ACS Omega. 2018 Nov 30;3(11):14726-14731
pubmed: 30533574
J Org Chem. 2010 Oct 15;75(20):6953-60
pubmed: 20857920
Angew Chem Int Ed Engl. 2018 Mar 19;57(13):3298-3321
pubmed: 28944552
Med Res Rev. 2016 May;36(3):494-575
pubmed: 26992114
Nat Rev Cancer. 2010 Jan;10(1):9-22
pubmed: 20029421
Science. 1987 Oct 23;238(4826):491-7
pubmed: 2821619
Curr Top Med Chem. 2016;16(3):314-29
pubmed: 26126915
Molecules. 2017 Aug 01;22(8):
pubmed: 28763044
Invest New Drugs. 2005 Jun;23(3):213-24
pubmed: 15868377
Nat Prod Rep. 2013 Jul;30(7):924-40
pubmed: 23732943
Chemistry. 2019 Feb 1;25(7):1696-1700
pubmed: 30452790
Lab Invest. 2001 Dec;81(12):1615-26
pubmed: 11742032
Angew Chem Int Ed Engl. 2002 Oct 18;41(20):3767-74
pubmed: 12386845
Chem Rev. 2017 Oct 11;117(19):12133-12164
pubmed: 28898067
ChemistryOpen. 2016 Dec 09;6(1):128-136
pubmed: 28168158